Know Cancer

or
forgot password


Phase 1
N/A
85 Years
Open (Enrolling by invite only)
Both
Colon Cancer

Thank you

Trial Information


Inclusion Criteria:



- pathologic proven colon cancer

Exclusion Criteria:

- Tumor located in distal transverse colon, splenic flexure, and descending colon

- distant metastasis

- acute obstruction and/or perforation

- associated with FAP or HNPCC

- synchronous malignancy

- ASA score 3 or 4

- pregnancy

- no consent

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

rate of intraoperative complication

Outcome Time Frame:

1 day

Safety Issue:

Yes

Principal Investigator

Suk Hwan Lee, MD. PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Kyung Hee University School of Medicine

Authority:

South Korea: Korea Food and Drug Administration (KFDA)

Study ID:

KHNMC IRB 2010-007

NCT ID:

NCT01203969

Start Date:

June 2010

Completion Date:

March 2011

Related Keywords:

  • Colon Cancer
  • Colonic Neoplasms

Name

Location